Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Modulation of mitochondrial dysfunction for treatment of disease
Michael Webb1, Dionisia P Sideris1, Margaret Biddle1
1Mitobridge Inc, an Astellas Company, 1030 Massachusetts Ave, Cambridge, MA 02138, USA.
Abstract:
Mitochondrial dysfunction is a causative and/or exacerbating feature of many pathologies. We discuss below approaches to modulate mitochondrial dysfunction that involve (1) increasing their energetic efficiency by targeting gene expression regulators such as PPAR or AMPK, (2) using antioxidant compounds to reduce the toxic reactive oxygen species mitochondria produce under stress, or (3) modulating aspects on the innate mitochondrial quality control system. The latter comprise linked processes of biogenesis, dynamic morphological changes, and elimination of defective mitochondria by mitophagy. We discuss representative compounds in all three classes.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Animal Mitochondrial Genetics
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

